Indeed, the interaction between B7 and CD28 on TILs is a positive activation signal; however, in Lum 3 BC, the CTLA-4 (CD28 competitive receptor) and PD1/PD-L1 pathway in immune cells and endothelial cells delivers an inhibitory signal (Figure 1). The gene discussed is CD274; the disease is breast cancer.